Skip to content
HowShorted

Dyne Therapeutics, Inc. short interest in 2022

In 2022, Dyne Therapeutics, Inc.'s disclosed short interest ran from 5.28% of shares outstanding on 14 Jan 2022 to 4.69% on 30 Dec 2022, a change of -0.59 percentage points. The year's high was 7.39% on 30 Jun 2022 and its low 1.97% on 15 Aug 2022, averaging 4.21% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.32 days on 15 Jun 2022. Full history: Dyne Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Dyne Therapeutics, Inc. in 2022

2022 in figures

Start of year
5.28% (14 Jan 2022)
End of year
4.69% (30 Dec 2022)
Change
-0.59 pp
High
7.39% (30 Jun 2022)
Low
1.97% (15 Aug 2022)
Average
4.21%
Highest days to cover
20.32 (15 Jun 2022)
SEC filings marked
8

Every report in 2022

Dyne Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20225.28%14.90
31 Jan 20224.21%3.75
15 Feb 20224.44%12.89
28 Feb 20224.58%12.13
15 Mar 20223.26%9.8910-K filed, results (8-K)
31 Mar 20223.17%9.03
14 Apr 20223.20%16.57
29 Apr 20223.23%10.88
13 May 20223.15%11.5710-Q filed, results (8-K)
31 May 20223.06%11.22
15 Jun 20227.31%20.32
30 Jun 20227.39%15.82
15 Aug 20221.97%3.9110-Q filed, results (8-K)
31 Aug 20222.33%5.85
15 Sep 20222.45%3.29
30 Sep 20223.40%4.82
14 Oct 20224.35%12.82
31 Oct 20225.33%11.44
15 Nov 20225.46%15.8910-Q filed, results (8-K)
30 Nov 20225.18%13.69
15 Dec 20225.29%4.46
30 Dec 20224.69%10.94

See also: Dyne Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.